دورية أكاديمية
Synthesis and computational study of metal complex of α-mangostin as an anticancer candidate
| العنوان: | Synthesis and computational study of metal complex of α-mangostin as an anticancer candidate |
|---|---|
| المؤلفون: | Richa Mardianingrum, Srie Rezeki Nur Endah, Isti Daruwati, Muchtaridi Muchtaridi, Ruswanto Ruswanto |
| المصدر: | Journal of Pharmacy & Pharmacognosy Research, Vol 12, Iss 3, Pp 423-438 (2024) |
| بيانات النشر: | GarVal Editorial Ltda., 2024. |
| سنة النشر: | 2024 |
| المجموعة: | LCC:Therapeutics. Pharmacology LCC:Pharmacy and materia medica |
| مصطلحات موضوعية: | cobalt, iron, a-mangostin, metal complex, platinum, Therapeutics. Pharmacology, RM1-950, Pharmacy and materia medica, RS1-441 |
| الوصف: | Context: The number of breast cancer patients from year to year is increasing, accompanied by an increase in global mortality; the position in Indonesia has reached 60-70% with end-stage conditions. ERα antiproliferative activity exists in α-mangostin compounds, but this compound still has several physicochemical problems, including its solubility. Therefore, efforts are needed to increase the activity of α-mangostin and its affinity as an alpha estrogen receptor antagonist through a structure-based design method. Aims: To obtain new compounds derived from α-mangostin in the form of a metal complex with cobalt (AM-Co), platinum (AM-Pt), and iron (AM-Fe) as medicinal ingredients that can be used as breast cancer therapeutic agents. Methods: The research methods include in silico studies (pharmacokinetic and toxicity prediction, molecular docking, and molecular dynamics), semi-synthesis to form a complex compound, and testing cytotoxic activity against MCF-7 and T-47D human breast cancer cells. Results: From the in vitro test results, it can be seen that the AM-Pt compound showed the best anticancer activity on MCF-7 cells compared to others from IC50 and SI values; this was supported by the results of in silico studies either through molecular docking or molecular dynamics, where this compound was more effective. Conclusions: Furthermore, it can be used as an anticancer candidate; particularly, its activity is predicted to be more potent as an ERa antagonist than a-mangostin and cisplatin. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English Spanish; Castilian |
| تدمد: | 0719-4250 |
| Relation: | https://jppres.com/jppres/pdf/vol12/jppres23.1827_12.3.423.pdf; https://doaj.org/toc/0719-4250 |
| DOI: | 10.56499/jppres23.1827_12.3.423 |
| URL الوصول: | https://doaj.org/article/a0a69ba312d34ceaae905e0bae676d80 |
| رقم الأكسشن: | edsdoj.0a69ba312d34ceaae905e0bae676d80 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 07194250 |
|---|---|
| DOI: | 10.56499/jppres23.1827_12.3.423 |